Prognostic indicators in ovarian serous borderline tumours.
Malpica A, Longacre TA.
Pathology. 2018 Feb;50(2):205-213. doi: 10.1016/j.pathol.2017.12.001. Epub 2017 Dec 28.
Needleoscopic Conservative Staging of Borderline Ovarian Tumor.
Gueli Alletti S, Rossitto C, Perrone E, Cianci S, De Blasis I, Fagotti A, Scambia G.
J Minim Invasive Gynecol. 2017 May-Jun;24(4):529-530. doi: 10.1016/j.jmig.2016.10.009. Epub 2016 Oct 27.
Assessing the landscape of ovarian serous borderline tumors.
Messini I, Doulgeraki T, Chrysanthakis D, Yiannou P, Gavresea T, Papadimitriou C, Panoskaltsis T, Voulgaris Z, Vlachos A, Pavlakis K.
Int J Gynecol Cancer. 2019 Mar;29(3):572-578. doi: 10.1136/ijgc-2018-000086. Epub 2019 Jan 18.
Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
Chamberlin MD, Eltabbakh GH, Mount SL, Leavitt BJ.
Gynecol Oncol. 2001 Jul;82(1):212-5. doi: 10.1006/gyno.2001.6234.
MORPHOPHENOTYPIC CHARACTERISTICS OF OVARIAN SEROUS BORDERLINE TUMORS.
Munjishvili V, Barabadze E, Musashvili T, Gachechiladze M, Burkadze G.
Georgian Med News. 2019 May;(290):20-25.
Management of borderline ovarian tumours.
Gershenson DM.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59. doi: 10.1016/j.bpobgyn.2016.09.012. Epub 2016 Oct 3.
Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature.
Ludovisi M, Foo X, Mainenti S, Testa AC, Arora R, Jurkovic D.
J Clin Ultrasound. 2015 Nov-Dec;43(9):573-7. doi: 10.1002/jcu.22266. Epub 2015 Feb 23.
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K, Bendifallah S, Dion L, Ouldamer L, Levêque J.
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):277-286. doi: 10.1016/j.gofs.2020.01.015. Epub 2020 Jan 28.
Intratesticular Mullerian Serous Borderline Tumor With Microinvasion: A Rare Tumor and Review of the Literature.
Repetto F, Perrino CM, Hirsch MS.
Int J Surg Pathol. 2024 Dec;32(8):1567-1573. doi: 10.1177/10668969241232702. Epub 2024 Mar 21.
Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I, Darb-Esfahani S, Sehouli J.
BJOG. 2016 Mar;123(4):498-508. doi: 10.1111/1471-0528.13840. Epub 2015 Dec 25.
